drugset
Drugs / E/C/F/TDF
last change Mar 2015 re-read 2 minutes ago

E/C/F/TDF

also known as elvitegravir/cobicistat/emtricitabine/tenofovir DF · STB
Developed for
AIDS
Investigated by
Gilead Sciences

Trials 1 · a red edge is where a trial was stopped

today NCT01363011 · Ph 3
20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT01363011 May 2011 → Jan 2013 AIDS Gilead Sciences Completed No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as E/C/F/TDF ClinicalTrials.gov intervention name — accepted as the source's own label NCT01363011 ↗
Known as elvitegravir/cobicistat/emtricitabine/tenofovir DF “elvitegravir/cobicistat/emtricitabine/tenofovir DF (STB, n = 33) achieved high rates of virologic success” PMID 25469527 ↗ Mar 2015
Known as STB “elvitegravir/cobicistat/emtricitabine/tenofovir DF (STB, n = 33) achieved high rates of virologic success” PMID 25469527 ↗ Mar 2015
Route Oral “administered orally once daily” NCT01363011 ↗